J Electroanal Chem Interfacial Electrochem 1986, 209:417428
While not a spot treatment, most clients experience visible improvements in key areas often resistant to diet and exercise alone
Although physicians did not rank GI issues as highly as patients, physicians do clearly consider GI issues to be one of the major contributors to GLP1 RA discontinuation
Wilckens KA, Ferrarelli F, Walker MP, Buysse DJ
MT-II is associated with reported cases of benign nevi modification (darkening) and, more rarely, with dermatological concerns (warranting dermato-oncological surveillance in at-risk subjects)
At the moment, Mounjaro is a diabetes drug, but Pisano said that the FDA is currently examining data on whether to include it in the weight loss class, and that decision might come in October